1. Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models. Issue 5 (23rd March 2019) Authors: Sugawara, Tatsuo; Baumgart, Simon J.; Nevedomskaya, Ekaterina; Reichert, Kristin; Steuber, Holger; Lejeune, Pascale; Mumberg, Dominik; Haendler, Bernard Journal: International journal of cancer Issue: Volume 145:Issue 5(2019) Page Start: 1382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗